| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | BioNTech to close 3 sites in Germany after failed buyer search | ||
| Mo | Roche's Gazyva secures FDA nod for idiopathic nephrotic syndrome, extending autoimmune pivot | ||
| Mo | Eli Lilly's new initiative will take GLP-1s to lower-income nations | ||
| 25.09. | Merck's holistic HIV health hive buzzes with the help of actress Debbie Allen | ||
| 25.09. | AbbVie's Cerevel buyout delivers as FDA gives go-ahead to 1st-in-class Juvmo in Parkinson's disease | ||
| 25.09. | Merck, Eisai's Welireg-Lenvima combo lands FDA nod to jump the kidney cancer queue | ||
| 25.09. | Lundbeck to move US digs to Boston as it eyes bigger innovation frontiers | ||
| 25.09. | Fierce Pharma Week: A look at the biggest trends, campaigns and conversations | ||
| 25.09. | Fierce Pharma Asia-Lilly's $3.35B InnoCare deal; Korea's breakthrough; China's 5-year biotech plan | ||
| 25.09. | Eli Lilly blasted for 'promotional and emotive' language in GLP-1 press release | ||
| 25.09. | Lilly brings more heat to Novo with FDA nod for once-weekly insulin Onswik | ||
| 24.09. | Boehringer Ingelheim offloads Shanghai CDMO to local antibody developer | ||
| 24.09. | GSK slammed for 'grossly misleading' and 'totally unacceptable' behavior | ||
| 24.09. | Elevar wins FDA nod for bile duct cancer drug Lyrfigtu, a first for a Korean firm | ||
| 24.09. | Otsuka JV recalls one lot of sodium chloride over labeling issue | ||
| 24.09. | Glaukos courts NBA champion Stephen Curry for new keratoconus awareness campaign | ||
| 24.09. | Biogen springs social media kidney health campaign with Olympic gymnast Suni Lee | ||
| 23.09. | Novo CEO sees advantages in souping up NYSE listing: report | ||
| 23.09. | Eli Lilly CEO touts 70% share as Medicare GLP-1 program reaches 700K seniors | ||
| 23.09. | Cellares pens 2nd automation test with Asia-based cell therapy partner in 2 weeks | ||
| 23.09. | AstraZeneca recommits to youth health to dial funding past $100M | ||
| 22.09. | Bristol Myers cuts another 265 jobs tied to New Jersey headquarters | ||
| 22.09. | Par Health recalls IV sedative in US, flagging presence of cellulose, stopper material | ||
| 22.09. | 'Europe does not value what you do': 9 pharmas make urgent call for bloc to beef up innovation muscle | ||
| 22.09. | Travere CEO Eric Dube to step down after transforming the rare disease biotech |